Ocular Therapeutix
OCUL
#5754
Rank
โ‚ฌ1.11 B
Marketcap
5,08ย โ‚ฌ
Share price
-4.95%
Change (1 day)
-52.22%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -โ‚ฌ0.26 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are โ‚ฌ52.05 Million. In 2025 the company made an earning of -โ‚ฌ0.25 Billion a decrease over its 2024 earnings that were of -โ‚ฌ0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.26 Billion7.15%
2025 -โ‚ฌ0.25 Billion37.43%
2024 -โ‚ฌ0.18 Billion139.68%
2023 -โ‚ฌ73.6 Million13.65%
2022 -โ‚ฌ64.76 Million984.05%
2021 -โ‚ฌ5.98 Million-95.79%
2020 -โ‚ฌ0.15 Billion80.19%
2019 -โ‚ฌ78.74 Million44.01%
2018 -โ‚ฌ54.68 Million-5.38%
2017 -โ‚ฌ57.79 Million41.79%
2016 -โ‚ฌ40.76 Million12.47%
2015 -โ‚ฌ36.24 Million38.75%
2014 -โ‚ฌ26.12 Million115.12%
2013 -โ‚ฌ12.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-โ‚ฌ10.22 Million-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-โ‚ฌ4.67 Million-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-โ‚ฌ0.15 Billion-46.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚ฌ0.16 B-158.70%๐Ÿ‡บ๐Ÿ‡ธ USA